NOSOTROS:

Genomma Lab Internacional International

Visit all our countries: Argentina Brasil Chile Colombia Ecuador Mexico Peru USA English Spanish English Spanish Investors Country International Argentina Brasil Chile Colombia Ecuador Mexico Peru USA Company About Us Corporate Social Responsibility Contact Company About Us Investors Corporate Social Responsibility Contact Genomma Lab Q3 2020 Earnings Release 2019 Annual Report "Empower people to have amazing health and wellness" "Empoderamos a las personas para tener excelente salud y bienestar" "Empoderar as pessoas a terem uma saúde e bem estar incríveis"

Gen Book 2018Company

Genomma Lab Internacional S.A.B. de C.V one of the leading pharmaceutical and personal care products companies in Mexico with an increasing international presence, develops, sells and markets a broad range of Premium brandend products, many of which are leaders in their categories. Mr. Jorge Brake, Chief Executive Officer, commented: “Our strong third quarter performance was enabled by the extraordinary work of our teams, who remained agile and resilient in today’s challenging operating environment. We are realizing the benefits of the successful strategy we implemented almost two years ago- which is particularly attuned to times of crisis- and of Genomma’s ability to adapt our advantaged product portfolio to address consumers’ ever evolving needs. During the quarter our Company’s exceptional innovation, go-to-market capabilities and strengthened presence within critical channels again drove outstanding year-on-year and sequential results.” He added: Our team’s resilient mindset, combined with Genomma’s strategic capabilities and execution excellence, continue to turn challenges into opportunities. I’d like to express my deepest gratitude, pride and appreciation for the extraordinary performance across our organization which enable us to empower people to have excellent health and well-being.”Jorge Brake

Chief Executive Officer

October 21, 2020 Mission

To improve and preserve the health and well-being of our customers through innovative, safe and effective products, providing development opportunities to our collaborators, profitability to our shareholders and positively impacting our community and environment. Vision

To be the leading company in the pharmaceutical and personal care products markets in which we are active; and to be recognized for our positive impact on the health and welfare of people, communities and the environment. About Us USA110%

of net salesMéxico1 46%

of net salesLatAm1 44%

of net salesBrands +40

Points of sale +308,000

Countries 18

Collaborators 1,137

Sales 2019 (MXN mm) $12,713

(OTC: 48%2, PC: 52%3)EBITDA 2019 (MXN mm) $2,473

1As a percentage of 2019 consolidated sales, 2Over The Counter, 3Personal Care Genomma Lab is committed to enriching the well-being of our society by improving life quality of the consumers of our products via the investigation and analysis of the optimal ingredients for the development and commercializationof our personal care and OTC pharmaceutical products, and in so doing, generating the maximum levels of profitability possible for our investors.Rodrigo Herrera Aspra

Founder and Chairman of the Board

Investors Genomma Lab, a Mexican company that has changed the business model in the pharmaceutical industry, presents events, news and financial statements in our website for investors.

Visit website Corporate Social Responsibility Our People. Responsible Actions
The generation of value is the result of the commitment, talent and integrity of our team.

Our Communities. Responsible Actions
We redouble efforts in social welfare programs, both internally and externally.

Visit website contact

The quality of our products is what most interests us and the satisfaction of our customers is what pleases us the most. E-mail: atencion@genommalab.com Phone: 800 7171 305 Address: Avenida Antonio Dovalí
Jaime, número 70, torre C, piso 2,
despacho "A". Colonia Santa Fe.
C.P. 01210. Delegación Álvaro
Obregón, Ciudad de México. COPYRIGHT - GENOMMA LAB 2018 Farmacovigilancia privacy policy Legal X


CONTACTOS